The Effect of Fenofibrate on Endothelial Function and HDL [high density lipoprotein cholesterol] Physicochemical and Functional Characteristics in Patients With Coronary Heart Disease and LDL-C [low density lipoprotein cholesterol] at Goal
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fenofibrate (Primary)
- Indications Coronary artery disease; Hyperlipidaemia
- Focus Pharmacodynamics
- 10 Mar 2011 Biomarkers information updated
- 09 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 May 2008 The expected completion date has been extended from 1 Jun 2008 to 1 Jun 2009.